The European Medicines Agency is recommending a tightening of its guideline on first-in-human clinical trials to provide better protections for volunteers and a new approach to evaluating protocols that cover a number of different study parts. ---Subscribe to MedNous to access this article--- Clinical Research Regulation & Policy
